Pathlight Investors’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Pathlight Investors’s Portfolio TMDI Stock Details TMDI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$39K	Buy	+16,439	New	+$30.5K	0.03%	104

Other funds holding TMDI

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

HCM

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

SHA

Seneca House Advisors Richmond, Virginia $283M AUM 22.4% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Pathlight Investors's TMDI Position: Q4 2018 in Review

Pathlight Investors opened a new position in Titan Medical Inc. Ordinary Shares (TMDI) in Q4 2018: 16,439 shares worth $39K. The stake represents 0.03% of the portfolio and ranks #104 among its holdings.

43 funds tracked by Wall St. Rank hold TMDI as of Q4 2018.

Pathlight Investors held 16,439 shares of Titan Medical Inc. Ordinary Shares worth $39K as of Q4 2018.
Titan Medical Inc. Ordinary Shares was a new Pathlight Investors position in Q4 2018.
Titan Medical Inc. Ordinary Shares made up 0.03% of Pathlight Investors's portfolio in Q4 2018, its #104 holding.
43 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q4 2018.

Based on Pathlight Investors's 13F filing for Q4 2018, filed 19 Feb 2019.